Enlivex Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENLV and other ETFs, options, and stocks.About ENLV
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state.
CEOOren Hershkovitz
CEOOren Hershkovitz
Employees—
Employees—
HeadquartersNess Ziona, Tel Aviv
HeadquartersNess Ziona, Tel Aviv
Founded2012
Founded2012
Employees—
Employees—
ENLV Key Statistics
Market cap21.65M
Market cap21.65M
Price-Earnings ratio-1.33
Price-Earnings ratio-1.33
Dividend yield—
Dividend yield—
Average volume45.26K
Average volume45.26K
High today$1.00
High today$1.00
Low today$0.93
Low today$0.93
Open price$0.97
Open price$0.97
Volume26.23K
Volume26.23K
52 Week high$1.84
52 Week high$1.84
52 Week low$0.8101
52 Week low$0.8101
ENLV News
TipRanks 5d
Enlivex Completes Phase II Enrollment for Osteoarthritis TrialEnlivex ( (ENLV) ) has issued an update. On April 21, 2025, Enlivex Therapeutics announced the completion of patient enrollment in the Phase II stage of its Ph...